What the six lenses say about AUROPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How AUROPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +1.6pp | +2.6pp | +6.0pp | +18.0pp | +39.1pp | +46.0pp |
Nifty 500 Broad-market baseline | +1.2pp | +2.5pp | +5.4pp | +14.4pp | +34.1pp | +42.2pp |
Sector Own-sector index | — | — | +3.0pp | +1.9pp | +19.7pp | +24.3pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
AUROPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AUROPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 7,567 | 7,796 | 7,979 | 8,382 | 7,868 | 8,286 | 8,646 | 8,853 |
| ↳ change QoQ | — | +3.0% | +2.3% | +5.1% | -6.1% | +5.3% | +4.3% | +2.4% |
| EBITDA (₹cr) | 1,841 | 1,702 | 1,735 | 1,760 | 1,603 | 1,678 | 1,773 | 1,750 |
| EBITDA margin | 24.3% | 21.8% | 21.8% | 21.0% | 20.4% | 20.3% | 20.5% | 19.8% |
| PAT (₹cr) | 918 | 817 | 846 | 903 | 824 | 848 | 910 | 921 |
| ↳ change QoQ | — | -11.0% | +3.5% | +6.8% | -8.7% | +2.9% | +7.3% | +1.2% |
| Net margin | 12.1% | 10.5% | 10.6% | 10.8% | 10.5% | 10.2% | 10.5% | 10.4% |
| EPS (₹) | 15.69 | 14.00 | 14.56 | 15.56 | 14.20 | 14.61 | 15.67 | 15.86 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding AUROPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HDFC Mid Cap Gr | 1.96% | 97,350 | |
| SBI Large & Midcap Reg Gr | 2.07% | 40,850 | |
| SBI ELSS Tax Saver Reg Gr | 0.74% | 31,839 | |
| HDFC Large and Mid Cap Gr | 1.08% | 28,515 | |
| SBI Midcap Reg Gr | 1.99% | 24,127 | |
| SBI Flexicap Reg Gr | 2.79% | 22,685 | |
| Bandhan Large & Mid Cap Gr | 0.96% | 17,461 | |
| Quant ELSS Tax Save rGr | 7.26% | 13,070 | |
| UTI Mid Cap Reg Gr | 2.05% | 12,122 | |
| Nippon India Pharma Gr | 1.75% | 9,044 |
ETFs holding AUROPHARMA (10)